ESTRO Brachytherapy for Prostate Cancer 2018
˃ First Endpoint: Ablation of clinically significant carcinoma (>0,5 cc) with negative biopsy at 12 months
*Van den Bos et al. Eur Urol 2014
Made with FlippingBook - Online catalogs
˃ First Endpoint: Ablation of clinically significant carcinoma (>0,5 cc) with negative biopsy at 12 months
*Van den Bos et al. Eur Urol 2014
Made with FlippingBook - Online catalogs